Image-guided therapy firm BrainLab of Munich, Germany, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Monte Carlo dose calculation software algorithm.
Monte Carlo is designed for therapeutic photon beams supporting nearly all linear accelerator and multileaf collimator types. Monte Carlo is available as an option on the company's iPlan RT Dose treatment planning software.
With Monte Carlo, dose calculations can be completed within seconds for conformal beam and dynamic arc treatments, and within a few minutes for complex intensity-modulated radiation therapy cases.
Related Reading
Varian, BrainLab land Danish orders, July 25, 2008
Varian, BrainLab win Novalis Tx orders, January 24, 2008
Varian, BrainLab team up, September 19, 2007
Siemens, BrainLab bring intraoperative CT scanner to the U.S., March 20, 2007
BrainLab wins patent victory, February 8, 2007
Copyright © 2008 AuntMinnie.com
